Ledger.Open graph →

SEC Form D · Amendment · filed December 21, 2023

SYNNOVATION THERAPEUTICS, INC

Offering

$102.5M

Sold

$15.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

WILMINGTON, DE

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Wenqing Yao · Wilmington, DEExec · Director Reid Huber · Wilmington, DEDirector Drew Walker · Boston, MADirector Anthony F. Mirra · New York, NYExec · Director Isaac Kato · Bellevue, WAExec · Director Ting Feng · Wilmington, DEDirector Wenqing Yao · Wilmington, DEExec · Director Liangxing Wu · Wilmington, DEExec · Director Mathilde Sanson · Camas, WADirector Ting Feng · Wilmington, DEDirector Liangxing Wu · Wilmington, DEExec · Director Reid Huber · Wilmington, DEDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗